Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05233800 · ClinicalTrials.gov registry record · NA

mHealth for Breast Cancer Survivors With Insomnia

A NA study of Insomnia and Breast Cancer Survivor, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT05233800 is a NA study of Insomnia and Breast Cancer Survivor that has completed, run by Medstar Health Research Institute. The registered enrollment target is 76 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05233800, a NA study of Insomnia and Breast Cancer Survivor, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.

Interventions

  • BEHAVIORAL Faster Asleep Smart Speaker Program
  • BEHAVIORAL Faster Asleep Website

Study Locations (1)

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2022-04-05
Est. Completion 2023-12-15
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT05233800

The ClinicalTrials.gov registry entry for NCT05233800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (55% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Faster Asleep Smart Speaker Program is the first listed.

NCT05233800 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05233800 about?

NCT05233800 is a clinical study titled "mHealth for Breast Cancer Survivors With Insomnia". The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.

What is the current status of trial NCT05233800?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2022-04-05. Estimated completion is 2023-12-15.

What conditions does trial NCT05233800 study?

This clinical trial studies the following conditions: Insomnia, Breast Cancer Survivor.

What interventions are being tested in trial NCT05233800?

The interventions under investigation include: Faster Asleep Smart Speaker Program (BEHAVIORAL), Faster Asleep Website (BEHAVIORAL).

Who is sponsoring clinical trial NCT05233800?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05233800 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.